The epidemiology of premenstrual syndrome

Primary Psychiatry

Volumn 11, Issue 12, 2004, Pages 27-32

  Johnson, Susan R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ABSENTEEISM; ALTERNATIVE MEDICINE; CLINICAL TRIAL; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET THERAPY; DISEASE SEVERITY; EXERCISE; FAMILY HISTORY; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HERBAL MEDICINE; HEREDITY; HIGH RISK POPULATION; HUMAN; HUMAN RELATION; IRRITABILITY; MAJOR DEPRESSION; MENSTRUAL CYCLE; MENTAL HEALTH SERVICE; MOOD DISORDER; NUTRITIONAL SUPPORT; OUTPATIENT CARE; OVULATION; POPULATION RESEARCH; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PREVALENCE; PUERPERAL DEPRESSION; REVIEW; RISK FACTOR; SELF HELP; SOCIAL BEHAVIOR; SYMPTOMATOLOGY; WORK CAPACITY;

EID: 11144273254     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. ACOG committee opinion. Premenstrual syndrome. Number 155-April 1995 (replaces no. 66, January 1989) Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1995;50(1):80-84.
3. Andersch B, Wenderstam C, Hahn L, Ohman R. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gyneacol. 1986;5:39-49.
4. Sternfeld B, Swindle R, Chawla A, Long S, Kennedy S. Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol. 2002;99(6):1014-1024.
5. Angst J, Sellaro R, Merikangas KR, Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand. 2001;104(2):110-116.
6. Hartlage SA, Arduino KE. Toward the content validity of premenstrual dysphoric disorder: do anger and irritability more than depressed mood represent treatment-seekers' experiences? Psychol Rep. 2002;90(1):189-202.
7. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003;28 (Suppl 3):1-23.
8. Sveindottir H, Backstrom T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand. 2000;79(5):405-413.
9. Singh BB, Berman BM, Simpson RL, Annechild A. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med. 1998;4(3):75-79.
10. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med. 1988;33(4):340-346.
11. Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry. 1990;147(12):1634-1636.
12. Ramcharan S, Love EJ, Pick GH, Goldfien A. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors.[see comment]. J Clin Epidemiol. 1992;45(4):377-392.
13. Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32(1):119-132.
14. Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Clin Epidemiol. 2002;70(2):125-132.
15. Merikangas KR, Foeldenyi M, Angst J. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci. 1993;243(1):23-32.
16. Halbreich U. Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol. 1995;9(2-3):163-175.
17. Muse KN, Cetel NS, Futterman LA, Yen SC. The premenstrual syndrome. Effects of "medical ovariectomy." N Engl J Med. 1984;311(21):1345- 1349.
18. Casper RF, Hearn MT. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol. 1990;162(1):105-109.
19. Casson P, Hahn PM, Van Vugt DA, Reid RL. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol. 1990;162(1):99-105.
20. Borenstein JE, Dean BB, Endicott J, et al. Health and economic impact of the premenstrual syndrome. J Reprod Med. 2003;48(7):515-524.
21. Joffe H, Cohen LS, Harlow BL. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am J Obstet Gynecol. 2003;189(6):1523-1530.
22. Huerta-Franco MR, Malacara JM. Association of physical and emotional symptoms with the menstrual cycle and life-style. J Reprod Med. 1993;38(6):448-454.
23. Cleckner-Smith CS, Doughty AS, Grossman JA. Premenstrual symptoms. Prevalence and severity in an adolescent sample. J Adolesc Health. 1998;22(5):403-408.
24. Freeman EW, Rickels K, Schweizer E, Ting T. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med. 1995;25(2):309-315.
25. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.[see comment]. N Engl J Med. 1995;332(23):1529-1534.
26. Yonkers KA, Halbreich U, Freeman E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.[see comment]. JAMA. 1997;278(12):983-988.
27. Pearlstein T, Joliat MJ, Brown EB, Miner CM. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. Am J Obstet Gynecol. 2003;188(4):887-895.
28. Freeman EW, Sammel MD, Rinaudo PJ, Sheng L. Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynecol. 2004;103(5 Pt 1):960-966.
29. Binfa L, Castelo-Branco C, Blumel J, et al. Influence of psycho-social factors on climacteric symptoms. Maturitas. 2004;48(4):425-431.
30. Dean B, Borenstein J. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J Occup Environ Med. 2004;46(7):649-656.
31. Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med. 1999;8(2):122-128.
32. Stout AL, Grady TA, Steege JF, Blazer DG, George LK, Melville ML. Premenstrual symptoms in black and white community samples. Am J Psychiatry. 1986;143(11):1436-1439.
33. van den Akker OB, Stein GS, Neale MC, Murray RM. Genetic and environmental variation in menstrual cycle: histories of two British twin samples. Acta Genet Med Gemellol (Roma). 1987;36(4):541-548.
34. Condon JT. The premenstrual syndrome: a twin study. Br J Psychiatry. 1993;162:481-486.
35. Kendler KS, Karkowski LM, Corey LA, Neale MC. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry. 1998;155(9):1234-1240.
36. Treloar SA, Heath AC, Martin NG. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med. 2002;32(1):25-38.
37. Robinson RL, Swindle RW. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors. J Womens Health Gend Based Med. 2000;9(7):757-768.
38. Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski TA. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord. 1990;20(2):129-134.
39. Chuong CJ, Burgos DM. Medical history in women with premenstrual syndrome. J Psychosom Obstet Gynaecol. 1995;16(1):21-27.
40. Stout AL, Steege JF, Blazer DG, George LK. Comparison of lifetime psychiatric diagnoses in premenstrual syndrome clinic and community samples. J Nerv Ment Dis. 1986;174(9):517-522.
41. Bailey JW, Cohen LS. Prevalence of mood and anxiety disorders in women who seek treatment for premenstrual syndrome. J Womens Health Gend Based Med. 1999;8(9):1181-1184.
42. Leather AT, Holland EF, Andrews GD, Studd JW. A study of the referral patterns and therapeutic experiences of 100 women attending a specialist premenstrual syndrome clinic.[see comment]. J R Soc Med. 1993;86(4):199-201.
43. Chawla A, Swindle R, Long S, Kennedy S, Sternfeld B. Premenstrual dysphoric disorder: is there an economic burden of illness? Med Care. 2002;40(11):1101-1112.
44. Gallo JJ. Epidemiology of mental disorders in middle age and late life: conceptual issues. Epidemiol Rev. 1995;17(1):83-94.
45. Landen M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety. 2003;17(3):122-129.
46. Kim DR, Gyulai L, Freeman EW, Morrison MF, Baldassano C, Dube B. Premenstrual dysphoric disorder and psychiatric comorbidity. Arch Women Ment Health. 2004;7(1):37-47.